Miranda-Filho A, Piñeros M, Bray F

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 219-229
Archivo PDF: 1047.77 Kb.

RESUMEN

Objetivo. Presentar las estimaciones nacionales más recientes de la carga del cáncer de pulmón a nivel mundial en 185 países y de prevalencia de tabaquismo (%) por sexo. Material y métodos. Las estimaciones de incidencia y mortalidad por cáncer de pulmón para el año 2018 se extrajeron de la base de datos Globocan, la incidencia observada del último volumen de Incidencia de Cáncer en Cinco Continentes y la prevalencia de tabaquismo del Observatorio Mundial de la Salud/OMS. Resultados. En 2018, se estimaron más de dos millones de nuevos casos de cáncer de pulmón y 1.7 millones de muertes a nivel mundial, que representan 14% de los casos nuevos y 20% de las muertes por cáncer. Las tasas de incidencia mostraron grandes variaciones entre países. En hombres, se observaron principalmente tasas de incidencia estables o decrecientes, mientras que en mujeres se observó con frecuencia un incremento. Conclusión. Los resultados en mujeres refuerzan la necesidad de fortalecer las acciones preventivas de los gobiernos en el Convenio Marco de la OMS para el Control del Tabaco.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Globocan 2018 [Internet]. Lyon, France: International Agency for Research on Cancer. c2013- [cited 2018 Sep 23]. Available from: http:// globocan.iarc.fr

2. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 coun tries. Lancet. 2018;391(10125):1023-75. https://doi.org/10.1016/S0140- 6736(17)33326-3

3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592.

4. Peto J. That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer. 2012;107:406-7. https://doi.org/10.1038/ bjc.2012.97

5. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008. The MPOWER Package. Geneva: WHO, 2008. Available from: http://www.who.int/tobacco/mpower/gtcr_download/en/index.html

6. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries: Global Cancer Statistics 2018. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/ caac.21492

7. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (Eds). Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer, 2017. Available from: http://ci5.iarc.fr

8. United Nations Development Programme [Internet]. UNDP; c2017 [cited 2018 Sep 21]. Human Development Programme Index (HDI); [about 2 screens]. Available from: http://hdr.undp.org/en/content/humandevelopment- index-hdi

9. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (Eds). Cancer Incidence in Five Continents Plus (time trends) (electronic version). Lyon: International Agency for Research on Cancer, 2017. Available from: http://ci5.iarc.fr/CI5plus/Default.aspx

10. World Health Organization Global Health Observatory [internet]. WHO; [cited 2018 Sep 16]. Prevalence of tobacco smoking; [about 1 screen].Available from: https://www.who.int/gho/tobacco/use/en/

11. World Health Organization. WHO global report on trends in prevalence of tobacco smoking, 2015. Geneva: WHO, 2015. Available from: http:// apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf

12. Segi M, Kurihara M. Cancer mortality for selected sites in 24 countries (1950-1957). 2nd ed. Sendai: Tohoku University of Medicine, 1960.

13. Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96-101. https:// doi.org/10.1136/tobaccocontrol-2011-050294

14. Piñeros M, Sierra MS, Forman D. Descriptive epidemiology of lung cancer and current status of tobacco control measures in Central and South America. Cancer Epidemiol. 2016;44(suppl 1):S90-9. https://doi. org/10.1016/j.canep.2016.03.002

15. Alonso R, Piñeros M, Laversanne M, Musetti C, Garau M, Barrios E, et al. Lung cancer incidence trends in Uruguay 1990-2014: An age-period-cohort analysis. Cancer Epidemiol. 2018;55:17-22. https://doi.org/10.1016/j. canep.2018.04.012

16. Guo Y, Zeng H, Zheng R, Li S, Barnett AG, Zhang S, et al. The association between lung cancer incidence and ambient air pollution in China: A spatiotemporal analysis. Environ Res. 2016;144:60-5. https://doi. org/10.1016/j.envres.2015.11.004

17. Funatogawa I, Funatogawa T, Yano E. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949-2010. Bull World Health Organ. 2013;91:332-40. https://doi.org/10.2471/BLT.12.108092

18. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer. 2004;40(1):96-125. https://doi. org/10.1016/j.ejca.2003.08.005

19. Cao B, Hill C, Bonaldi C, León ME, Menvielle G, Arwidson P, et al. Cancers attributable to tobacco smoking in France in 2015. Eur J Public Health. 2018;28(4):707-12. https://doi.org/10.1093/eurpub/cky077

20. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases: 2013-2020. Geneva: WHO, 2013. Available from: http://apps.who.int/iris/bitstre am/10665/94384/1/9789241506236_eng.pdf

21. Dubray J, Schwartz R, Chaiton M, O’Connor S, Cohen JE. The effect of MPOWER on smoking prevalence. Tob Control. 2015;24(6):540-2. https:// doi.org/10.1136/tobaccocontrol-2014-051834

22. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 2009;9:655-64. https://doi.org/10.1038/nrc2703